Next Generation Integrase Inhibitor from GSK (S/GSK1349572)

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
818 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Aug 4, 2009

Garrett Nichols, GlaxoSmithKline, Project Leader, discusses GSK's new Integrase Inhibitor under development, it's dosing, and cross resistance with Merck's Raltegravir.

Interviewed by Fred Schaich, IFARA, at the 5th IAS Conference in Cape Town, South Africa, July 2009.

Category:

Education

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (1)

Sign In or Sign Up now to post a comment!
  • Ral is gerat

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more